SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biochem Pharma (BCHE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: JDN who wrote (690)12/29/1999 11:06:00 AM
From: tuck  Read Replies (1) of 783
 
JDN,

I got called out of this stock this month, but I bought back in on the continued weakness. I now have a bigger position at ~20 1/2. My plan is to write January 22 1/2 calls in the next week. Then I'll hold to see what the end of January news is for BCHE. I don't know if you dabble in options, but it seems like a good way to lower your average cost to the current market price without much likelihood of sacrificing the coming upside, since the news will come out well after expiration.

FWIW, The folks at the IMGN thread were hoping BCHE would announce an IND involving IMGN's technology at the recent conferences. If their expectations can be taken as a fair proxy for the Street's, that might explain why BCHE is still weak, since no such announcements were made.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News